Of note, the three responsive ovarian cancer cell lines (SKOV3, HEYA8 and IGROV1) exhibited markedly decreased BRCA1/2 expression at both mRNA and protein levels upon BKM120 or BKM120/Olaparib treatment (Figure 5B and 5C). This evidence concerns the gene BRCA1 and ovarian carcinoma.